Table 3.
Predictor(independent) variable | Complication N (%) | No complication n (%) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|
O.R. 95% C.I. | p-value | O.R. 95% C.I. | p-value | |||
Age (in years) | ||||||
<40 | 15 (28.8) | 37 (71.2) | ||||
≥40 | 10 (31.2) | 22 (68.8) | 3.91(0.94-5.23) | 0.167 | 1.23(0.93-2.34) | 0.786 |
Sex | ||||||
Male | 14 (29.2) | 36 (70.8) | ||||
Female | 11 (30.6) | 25 (69.4) | 1.87(0.22-4.88) | 0.334 | 3.32(0.45-4.66) | 0.937 |
Premorbid illness | ||||||
Yes | 4 (66.7) | 2(33.3) | ||||
No | 21(26.9) | 57(73.1) | 3.54(1.33-5.87) | 0.012 | 5.28(2.39-6.82) | 0.007 |
Previous PUD | ||||||
Yes | 7(26.9) | 19(73.1) | ||||
No | 18(31.0) | 40(69.0) | 0.21(0.11-1.78) | 0.051 | 1.65(0.32-2.89) | 0.786 |
NSAIDs use | ||||||
Yes | 3(33.3) | 6(66.7) | ||||
No | 22(29.3) | 53(70.7) | 1.98(0.99-3.91) | 0.923 | 1.02(0.78-3.90) | 0.123 |
Alcohol use | ||||||
Yes | 22(30.6) | 50(69.4) | ||||
No | 3(25.0) | 9(75.0) | 3.05(0.19-2.86) | 0.054 | 0.45(0.22-5.21) | 0.321 |
Cigarette smoking | ||||||
Yes | 17(31.5) | 37(68.5) | ||||
No | 8(26.7) | 22(73.3) | 3.11(0.44-5.23) | 0.145 | 3.02(0.99-4.56) | 0.334 |
Treatment delay | ||||||
< 48 | 18(90.0) | 2(10.0) | ||||
≥ 48 | 7(14.6) | 41(85.4) | 1.06(1.01-5.45) | 0.021 | 0.23(0.11-0.95) | 0.003 |
HIV status | ||||||
Positive | 6(75.0) | 2 (25.0) | ||||
Negative | 19(25.0) | 57(75.0) | 2.87(1.22-4.97) | 0.023 | 1.92(1.31-4.22 | 0.001 |
CD4 count | ||||||
<200 cells/μl | 1 (50.0) | 1(50.0) | ||||
≥ 200 cells/μl | 1(16.7) | 5(83.3) | 4.05(3.27-5.01) | 0.029 | 2,94(2.44-6.98) | 0.000 |
Nature of perforation | ||||||
Acute | 24(32.4) | 50(67.6) | ||||
Chronic | 1(10.0) | 9(90.0) | 4.94(2.84-8.92) | 0.009 | 2.95(1.11-6.98) | 0.018 |